Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Part 1 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data from the ACTT-1 trial comparing remdesivir vs placebo for severe COVID-19 treatment. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management.
Content based on an online CME program supported by an independent educational grant from Gilead Sciences.
Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
New York, New York
Senior Scientific Director
Executive Vice President
Associate Scientific Director
This program has been made available online.
Sharon R. Lewin AO, FRACP, PhD, FAHMS, provides a brief update on COVID-19 and answers clinician questions in the CCO Infectious Disease podcast
Download free slides reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis, symptoms, management, and treatment
Professor Leo Yee-Sin discusses data on the incidence of community- and hospital-acquired secondary infections in patients with COVID-19, from CCO
Wong Chen Seong, MBBS, MRCP(UK), FAMS, provides a brief update on COVID-19 and answers clinician questions in the CCO Infectious Disease podcast